You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: April 25, 2024

Details for Patent: 9,815,820


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 9,815,820
Title:Rho kinase inhibitors
Abstract: The invention relates to inhibitors of ROCK1 and/or ROCK2. Also provided are methods of treating diseases and disorders involving inhibiting ROCK1 and/or ROCK2.
Inventor(s): Poyurovsky; Masha (New York, NY), Kim; Ji-In (Princeton, NJ), Liu; Kevin (West Windsor, NJ), Zanin-Zhorov; Alexandra (Staten Island, NY)
Assignee: Kadmon Corporation, LLC (New York, NY)
Application Number:14/431,936
Patent Claim Types:
see list of patent claims
Use; Compound;

Drugs Protected by US Patent 9,815,820

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Kadmon Pharms Llc REZUROCK belumosudil mesylate TABLET;ORAL 214783-001 Jul 16, 2021 RX Yes Yes ⤷  Try a Trial ⤷  Try a Trial FOR THE TREATMENT OF CHRONIC GRAFT VERSUS HOLD DISEASE ⤷  Try a Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

Foreign Priority and PCT Information for Patent: 9,815,820

PCT Information
PCT FiledOctober 07, 2013PCT Application Number:PCT/US2013/063752
PCT Publication Date:April 10, 2014PCT Publication Number: WO2014/055996

International Family Members for US Patent 9,815,820

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Canada 2926478 ⤷  Try a Trial
Canada 3151343 ⤷  Try a Trial
China 105120869 ⤷  Try a Trial
China 113620933 ⤷  Try a Trial
China 113637007 ⤷  Try a Trial
China 113637008 ⤷  Try a Trial
China 113773308 ⤷  Try a Trial
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.